Coinbase Co-founder Fred Ehrsam raised $100 million in Series A funding for Nudge, a brain-tech startup aiming to enhance human cognition. Thrive Capital and Greenoaks Capital led the round, alongside several angel investors.
Ehrsam confirmed the raise on X, noting the company’s mission to make everyone’s brain function better through engineering innovation.
In April, Nudge launched its first human-ready system called the ‘Nudge Zero.’ Since then, the device has been used daily in research studies. The team is actively improving the platform through real-time tests.
Nudge has stated that its innovative brain interfaces are safe and non-invasive and also precise. According to the company, more than half of the global population could face a brain disorder at some point in their lives.
Nudge is actively working to combine advanced hardware, physics modeling, and signal processing to deliver real-time brain feedback systems. The aim is to optimize brain function without surgery or drugs. Hence, the startup is working to build interfaces that interact directly with the brain.
The backing from Thrive and Greenoaks shows a growing trust in neurotechnology. With the $100 million investment, Nudge can speed up its research, enhance its platform, and get its devices out to more people.
Meanwhile, Coinbase has also teamed up with PNC Bank. Their partnership plan is to make cryptocurrency more accessible for both retail and institutional clients. A recent press release shared that through Coinbase’s Crypto-as-a-Service platform, PNC users can securely buy, sell, or hold digital assets.
This partnership fits with the increasing support from U.S. regulators for digital finance. As a result, Coinbase and Nudge are leveraging cutting-edge technologies to pave the way for the future of finance and health tech.